NLRP3 and gout: Identification of the NLRP3 inflammasome as having a role in the recognition of MSU crystals and the subsequent release of IL-1β was a milestone in understanding the pathogenesis of gout [22], and this pivotal role of the NLRP3 inflammasome presents an attractive target for the potential treatment of gout.